IL-2 immunotherapy-induced increase in IL-12 blood concentrations may depend on an increase in circulating dendritic cell number.
Lissoni
P
P
Bucovec
R
R
Meregalli
S
S
Fumagalli
L
L
Vigorè
L
L
Ferrante
R
R
Brivio
F
F
D000368:Aged; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D002452:Cell Count; D003713:Dendritic Cells / Q000502:physiology*; D005260:Female; D006801:Humans; D018664:Interleukin-12 / Q000097:blood*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D008297:Male; D008875:Middle Aged
D007376:Interleukin-2; D018664:Interleukin-12